Oryzon Genomics S.A. (ORYZF)
OTCMKTS
· Delayed Price · Currency is USD
3.030
0.00 (0.00%)
At close: May 7, 2025
Oryzon Genomics Employees
Oryzon Genomics had 47 employees as of December 31, 2024. The number of employees increased by 1 or 2.17% compared to the previous year.
Employees
47
Change (1Y)
1
Growth (1Y)
2.17%
Revenue / Employee
$169,228
Profits / Employee
-$96,995
Market Cap
235.01M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 374 |
CytoDyn | 9 |
Northwest Biotherapeutics | 25 |
Silence Therapeutics | 116 |
American Oncology Network | 1,914 |
Oryzon Genomics News
- 16 days ago - ORYZON Awarded €13.26 Million Through the First Important Project of Common European Interest (IPCEI) in the Health Sector (Med4Cure Project) - GlobeNewsWire
- 4 weeks ago - ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat - GlobeNewsWire
- 2 months ago - ORYZON to Provide Corporate Progress Updates at Several Events in March-April - GlobeNewsWire
- 2 months ago - Oryzon Announces Publication of Study on Phelan-McDermid Syndrome (PMS) Patients, a Form of Autism, Paving the Way for a Novel Personalized Medicine Approach with Vafidemstat - GlobeNewsWire
- 3 months ago - ORYZON Announces the Voting Results of February 2025 Extraordinary General Shareholders' Meeting - GlobeNewsWire
- 3 months ago - ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31, 2024 - GlobeNewsWire
- 3 months ago - ORYZON Announces Journal Publication of Final Phase IIa REIMAGINE Results with Vafidemstat in Psychiatry and Clinical Neurosciences - GlobeNewsWire
- 4 months ago - ORYZON to Reshape Its Board of Directors at the Upcoming Shareholders' Meeting - GlobeNewsWire